Evidence map›Paper›PMID 42755549›Full record

ArticleFrontiers in cellular and infection microbiology2026

Genomic insights and evaluation of

Merihan S Sabra, Lina Jamil M Abdel-Hafez, Amr S Bishr, Hesham Ali El Enshasy, Mohamed H Al-Agamy, Khalid Alyahya, Khaled M Aboshanab

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Merihan S SabraDepartment of Microbiology and Immunology, Faculty of Pharmacy, October 6 University, Giza, Egypt.
Lina Jamil M Abdel-HafezDepartment of Microbiology and Immunology, Faculty of Pharmacy, October 6 University, Giza, Egypt.
Amr S BishrDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Hesham Ali El EnshasyInnovation Centre in Agritechnology in Advanced Bioprocessing (ICA), Universiti Teknologi Malaysia, Higher Education Hup, Pagoh, Johor, Malaysia.
Mohamed H Al-AgamyDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Khalid AlyahyaDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Khaled M AboshanabDepartment of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary metabolites are promising alternatives due to their diverse biological activities, including antimicrobial and antiviral effects. Wild plants, particularly

Indexed as

BacillusEndophytesSolanumAnti-Infective AgentsAntiviral AgentsGenome, BacterialGenomicsHerpesvirus 1, HumanMicrobial Sensitivity TestsPhylogenyPlant LeavesWhole Genome SequencingAnti-Infective AgentsAntiviral AgentsantiviralBacillus spizizeniiendophyteSolanum elaeagnifoliumwhole genome sequencing

Identifiers

PMID42755549
PMCPMC13581695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.